PubRank

N L Shimanovskiĭ

Author PubWeight™ 3.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [The action of methandrostenolone and ecdysterone on the physical endurance of animals and on protein metabolism in the skeletal muscles]. Farmakol Toksikol 1989 0.81
2 [Effect of steroid hormones on production of reactive oxygen species in mitochondria]. Biofizika 2012 0.76
3 [A new Russian gestagen with anticancer activity]. Vestn Ross Akad Med Nauk 2007 0.76
4 [Antihypertensive and neuroprotective activity of quercetin and its derivatives]. Eksp Klin Farmakol 2012 0.75
5 [Proliferative activity of rat skin fibroblasts under the action of glucocorticoids and gestagens]. Eksp Klin Farmakol 2008 0.75
6 [The effect of x-ray contrast media on the blast transformation of human peripheral blood T-lymphocytes in vitro]. Eksp Klin Farmakol 1994 0.75
7 [Expanding the possibilities of using biphosphonates for prophylaxis and treatment of osteal complications in malignant metastasis]. Eksp Klin Farmakol 2005 0.75
8 [Efficiency of use of gadolinium drugs as contrast substances]. Vestn Rentgenol Radiol 2005 0.75
9 [Estrogens and brain]. Vestn Ross Akad Med Nauk 2012 0.75
10 [The receptors: from theory to practice]. Farmakol Toksikol 1990 0.75
11 [Effect of contrast media on the duration of lag period and rate of production of reactive oxygen species by neutrophils]. Biull Eksp Biol Med 1998 0.75
12 [A mathematical analysis of the relationship of the clinical manifestations of side effects to the blood biochemical indices in subjects undergoing x-ray contrast studies]. Vestn Rentgenol Radiol 1996 0.75
13 [Study of interaction between contrast media and human serum albumin by the fluorescence method]. Farmakol Toksikol 1977 0.75
14 [Contrast media: present status and future of their production and use]. Vestn Akad Med Nauk SSSR 1989 0.75
15 [Effects of contrast media on interleukin-2 levels in human plasma in vitro]. Biull Eksp Biol Med 1992 0.75
16 [On a mechanism of histamine-liberating effect of radiocontrast media]. Biull Eksp Biol Med 1996 0.75
17 [Alternative experiments in pharmacology and radiobiology (education experience at the Molecular Pharmacology and Radiobiology Division of the Department of Medical Biology of N I Pirogov Russian State Medical University)]. Eksp Klin Farmakol 2010 0.75
18 [Comparison of the effect of various contrast media on the in vitro chemiluminescence of peritoneal macrophages of rats]. Biull Eksp Biol Med 1998 0.75
19 [Phospholipase A2 activity in the rat skin tissues in the norm and under hormone exposure]. Biull Eksp Biol Med 2000 0.75
20 [The mechanisms of the interaction of contrast media with serum albumin and gamma-globulin studied by means of fluorescence extinction and equilibrium dialysis]. Eksp Klin Farmakol 1997 0.75
21 [Prevention of contrast-induced nephropathy in the context of evidence-based medicine]. Vestn Rentgenol Radiol 2014 0.75
22 [Changes in the production of active oxygen species in neutrophils caused by contrast media]. Biull Eksp Biol Med 1997 0.75
23 [MMR visualization with contrast magnification for diagnosis of urinary diseases. I. Diagnosis of morphological and functional disorders. MR angiography of the kidneys]. Urologiia 2007 0.75
24 [Lowering of nephropathy risk during angiography procedure. What are choice criteria for the radiocontrast media?]. Angiol Sosud Khir 2003 0.75
25 [Antiaggregant and antioxidant activity of estradiol and tamoxifen]. Eksp Klin Farmakol 2004 0.75
26 [Effect of x-ray contrast materials on erythrocyte hemolysis]. Farmakol Toksikol 1977 0.75
27 [Problems of drug recognition. Imipramine receptors]. Farmakol Toksikol 1986 0.75
28 [Changes in the levels of prostaglandin F 2alpha, leukotriene C4 and B4 in the rat blood after intravenous administration of radiocontrast media]. Biull Eksp Biol Med 1997 0.75
29 [Molecular mechanisms of gestagen action]. Eksp Klin Farmakol 2011 0.75
30 [Empiric treatment of pyelonephritis]. Urologiia 2011 0.75
31 [The effect of x-ray contrast agents on the concentration and size of immune complexes in the blood]. Farmakol Toksikol 1990 0.75
32 [Effects of ionic and non-ionic roentgen-contrast media upon ex vivo hemostasis in rabbits]. Eksp Klin Farmakol 2006 0.75
33 [Competitive interrelations between bilirubin and x-ray contrast agents in binding with human serum albumin]. Farmakol Toksikol 1986 0.75
34 [The pharmacology of purine receptors]. Farmakol Toksikol 1987 0.75
35 [Relative binding activity of dydrogesterone with blood mononuclear cells progesterone receptors of women included in the IVF program]. Eksp Klin Farmakol 2013 0.75
36 [Nephrotoxicity of X-ray contrast media]. Vestn Rentgenol Radiol 2001 0.75
37 [Histamine-releasing action of x-ray contrast media in rats in vivo]. Farmakol Toksikol 1988 0.75
38 [Effect of x-ray contrast agents on the deformation properties of human erythrocytes]. Biull Eksp Biol Med 1989 0.75
39 [Interaction of the new gestagen compound 17alpha-acetoxy-3beta-butanoyloxy-6-methylpregna-4,6-dien-20-one with human blood proteins and calf embryo serum]. Eksp Klin Farmakol 2008 0.75
40 [Effect of steroid sex hormones on lipid peroxidation and antiperoxide system of glutathione in rat skin tissues]. Biull Eksp Biol Med 1999 0.75
41 [The effect of x-ray contrast agents on the rheological properties of the blood]. Eksp Klin Farmakol 1994 0.75
42 [Interaction of 125I-omnipaque with the rat mononuclear phagocytes]. Biull Eksp Biol Med 1999 0.75
43 [Antitumor and antiproliferative action of the steroidal cytostatic antiestrogen cytestrol acetate on hormone-dependent tumor models]. Eksp Klin Farmakol 2014 0.75
44 [Safety of the currently available iodinated radiopaque contrast agents]. Vestn Rentgenol Radiol 2011 0.75
45 [The effect of nitroglycerin, nitrosorbide and nitroprusside on the intracellular content of Ca2+ ions in human lymphocytes]. Biull Eksp Biol Med 1992 0.75
46 [The dynamics of antigen-antibody complex formation in the presence of iodine-containing diagnostic agents]. Eksp Klin Farmakol 2000 0.75
47 [Contrast-enhanced magnetic resonance imaging in the diagnosis of urinary tract disease]. Vestn Rentgenol Radiol 2005 0.75
48 [Effect of x-ray contrast substances on the complement system of rats]. Biull Eksp Biol Med 1989 0.75
49 [Hemodynamic effects of contrast substances as dependent on their viscosity and osmolality]. Angiol Sosud Khir 2004 0.75
50 [Antiproliferative and antioxidant activity of new dihydroquercetin derivatives]. Eksp Klin Farmakol 2010 0.75
51 [Phenobarbital--an inducer of bilignost excretion with the bile in rats]. Farmakol Toksikol 1988 0.75
52 [The effect of x-ray contrast media on the amount of thromboxane and prostacyclin in the blood of man and rats in vivo and in vitro]. Eksp Klin Farmakol 1994 0.75
53 [Serum albumin--a transport receptor system for physiologically active substances]. Farmakol Toksikol 1984 0.75
54 [The protective effect of 17 beta-estradiol in experimental myocardial infarct]. Eksp Klin Farmakol 1996 0.75
55 [Interaction of human serum albumin with narcotic analgesics and barbiturates]. Farmakol Toksikol 1977 0.75
56 [Study of the microstructure of the water-protein layer of spin-labeled preparations of lysozyme by the magnetic relaxation method]. Biofizika 1977 0.75
57 [The effect of x-ray contrast media on the concentration of intracellular calcium in mononuclear cells]. Eksp Klin Farmakol 2000 0.75
58 [Visualization with contrast magnification for diagnosis of urinary disease. Part II. Renal function and unire excretion in conduction of excretory MR-urography. Novel MR technologies]. Urologiia 2007 0.75
59 [The effect of diagnostic contrast media on the activity of lactate dehydrogenase in rat blood]. Eksp Klin Farmakol 2002 0.75
60 [The use of magnetic resonance contrast agents for selective digital subtraction angiography and computed tomography with contrast enhancement]. Angiol Sosud Khir 2006 0.75
61 [Histamine-liberating action of x-ray contrast media]. Farmakol Toksikol 1988 0.75
62 [The effect of x-ray contrast media on the spontaneous hemolysis of human erythrocytes and the possible regulatory pathways]. Farmakol Toksikol 1991 0.75
63 [Effects of liposome form of triombrast on the state of blood and organ lipids in experimental animals]. Biull Eksp Biol Med 1990 0.75
64 [Effect of x-ray contrast agents on the thromboresistant properties of vascular walls]. Eksp Klin Farmakol 2009 0.75
65 [Effect of x-ray contrast agents on the blood (a review of the literature)]. Farmakol Toksikol 1978 0.75
66 [Effect of roentgenocontrast agents on bilirubin absorption by liver sections of rats]. Farmakol Toksikol 1986 0.75
67 [Serotonin receptors (results of the pharmacological study)]. Eksp Klin Farmakol 1998 0.75
68 [Anti-arrhythmia activity of estradiol valerate and estradiol nitrate]. Eksp Klin Farmakol 2003 0.75
69 [Effect of glucocorticoids and gestagens on the glutathione redox system in the rat skin during dermatitis]. Biull Eksp Biol Med 2000 0.75
70 [Symposium "Nephropathy Caused by Contrast Media" (in the program of the XLI congress of the European Kidney Association. 15-18 May, 2004, Lisbon)]. Urologiia 2005 0.75
71 [Dopamine receptors. Their role in regulating the activities of the heart and vessels]. Eksp Klin Farmakol 1998 0.75
72 [Antitumor activity of the new gestagen 17alpha-acetoxy-3beta-butanoyloxy-6-methyl-pregna-4,6-dien-20-one]. Eksp Klin Farmakol 2004 0.75
73 [Pharmacological properties of complex iron oxide nanoparticles entering in magnetic resonance tomography contrast agent]. Eksp Klin Farmakol 2010 0.75
74 [Design of contrast diagnostic agents for intravascular injection: from the first experiments to our days]. Vestn Rentgenol Radiol 2003 0.75
75 [Estimating ability of dihydroquercetin to inhibit oxidation of fibrinogen by ozone]. Eksp Klin Farmakol 2013 0.75
76 [Effect of contrast media on free calcium ion concentration in the rat blood in vivo]. Biull Eksp Biol Med 1998 0.75
77 [The biochemical and rheological properties of the blood during the performance of angiography using Ultravist]. Eksp Klin Farmakol 1996 0.75
78 [Comparative study of the effect of contrast media on the activity of complement system and eicosanoid levels in rat blood in vitro]. Biull Eksp Biol Med 1998 0.75
79 [Current status of antibiotic resistance of pyelonephritis causing pathogens]. Urologiia 2010 0.75
80 [The effect of iodine-containing x-ray contrast media on water status in the blood plasma]. Eksp Klin Farmakol 1994 0.75
81 [Deformation properties of human erythrocytes in the presence of x-ray contrast agents]. Eksp Klin Farmakol 2009 0.75
82 [On the possible development of anaphylactic/anaphylactoid reactions from the use of iodinated radiopaque agents]. Vestn Rentgenol Radiol 2013 0.75
83 [Molecular mechanisms of cytostatic and chemosensitizing action of gestagens]. Vestn Ross Akad Med Nauk 2010 0.75
84 [Pharmacology of benzodiazepine receptors]. Farmakol Toksikol 1986 0.75
85 [Genomic and extragenomic mechanisms of antiglucocorticoid action of gestagens on thymocytes]. Eksp Klin Farmakol 2006 0.75
86 [The effect of contrast agents on latex phagocytosis by mouse neutrophils]. Eksp Klin Farmakol 1999 0.75
87 [A dynamic study of the intensity of mitogenesis in an osteoblast culture in the presence of ultrasonically dispersed hydroxyapatite]. Stomatologiia (Mosk) 1998 0.75
88 [Theory of organotropism of roentgen contrast media]. Farmakol Toksikol 1983 0.75
89 [Bolus contrast-enhanced multislice spiral computed tomography of the chest: new possibilities in the diagnosis of lung diseases]. Vestn Rentgenol Radiol 2013 0.75
90 [The molecular mechanisms of the elimination of organic anions by the liver]. Eksp Klin Farmakol 1994 0.75
91 [Effect of contrast agents on the activity of acid phosphatase in mouse neutrophils]. Biull Eksp Biol Med 1998 0.75
92 [Cell membrane targets and steroid hormones: the beginning or end of the dispute?]. Biull Eksp Biol Med 1995 0.75
93 [GABA receptors and the cardiovascular system]. Eksp Klin Farmakol 1998 0.75
94 [Diagnostic effectiveness and safety of currently available X-ray contrast media]. Vestn Rentgenol Radiol 2000 0.75
95 [Effects of progesterone in various dosage forms on lipid peroxidation and glutathione redox system in skin tissues in rats with experimental dermatitis]. Biull Eksp Biol Med 2000 0.75
96 [Redox-dependent ferric oxide nanoparticles loaded with doxorubicin and their influence on the functions of mitochondria]. Biofizika 2015 0.75
97 [The effect of x-ray and NMR contrast agents on lipid peroxidation in the normal and pathological kidneys of rats]. Biull Eksp Biol Med 1993 0.75
98 [The complement-activating action of modern x-ray contrast agents]. Eksp Klin Farmakol 1998 0.75
99 [The action of x-ray contrast media on spontaneous erythrocyte aggregation]. Biull Eksp Biol Med 1991 0.75
100 [Transport of x-ray contrast media in isolated target and nontarget cells]. Farmakol Toksikol 1989 0.75
101 [Aggregation, deformation and morphology of erythrocytes in patients with ischemic heart disease after injection of ioversol, iodixanol and gadobutrol]. Eksp Klin Farmakol 2010 0.75
102 [The effect of ultrahigh-frequency electromagnetic radiation on learning and memory processes]. Biull Eksp Biol Med 1992 0.75
103 [Experimental study of indium-111 labeled octreotide application for radionuclide diagnostics of tumors with high expression of somatostatin receptors]. Eksp Klin Farmakol 2011 0.75
104 [Physicochemical mechanisms of the organotropism of drugs]. Vestn Akad Med Nauk SSSR 1984 0.75